Endoscopy 2001; 33(10): 873-875
DOI: 10.1055/s-2001-17341
Short Communication

© Georg Thieme Verlag Stuttgart · New York

Low Power Diode Laser Treatment Using Indocyanine Green for Eradication of Esophageal Varices

S. Hino 1 , H. Kakutani 1 , K. Ikeda 1 , H. Yasue 1 , K. Sumiyama 1 , Y. Uchiyama 1 , A. Kuramochi 1 , K. Matsuda 1 , H. Arakawa 1 , M. Kawamura 1 , K. Masuda 1 , H. Suzuki 1 , T. Hayashi 2 , N. Nakamura 2 , T. Arai 2 , M. Kikuchi 2
  • 1 Dept. of Endoscopy, Jikei University School of Medicine, Tokyo Japan
  • 2 Dept. of Medical Engineering, National Defense Medical College, Saitama, Japan
Further Information

Publication History

Publication Date:
20 September 2001 (online)

Background and Study Aims: Endoscopic variceal ligation (EVL) is an alternative to sclerotherapy for the treatment of esophageal varices, but is associated with higher rates of recurrence and subsequent bleeding than sclerotherapy. To prevent recurrence of varices after EVL, we have developed a low-dose diode laser therapy combined with the injection of indocyanine green, which allows enhanced tissue absorption of the laser beam selectively around varices. In this study we investigated the efficacy and safety of this technique.

Patients and Methods: Eight patients with F2 or F3 esophageal varices were enrolled. At 1 week after EVL, indocyanine green solution (1 mg/ml) was injected submucosally around the remaining varices. A diode laser (power 10 watts) was applied to the surface from the esophagogastric junction to 5 cm above it. The spot size was kept to 5 mm in diameter.

Results: Laser irradiation was performed safely, without bleeding from the varices, or perforation. There were no major complications. Endoscopy 1month later showed F0 forms in seven patients, F1 in one patient, and no red color sign in any patient. No recurrence of varices has been observed in any of the patients during the follow-up period of at least 12 months.

Conclusion: This technique may provide a simple, safe and effective procedure, as an additional treatment to EVL, for the prevention of recurrence of esophageal varices.

References

  • 1 Baroncini D, Milandri G, Borioni D, et al. A prospective randomized trial of sclerotherapy versus ligation in the elective treatment of bleeding esophageal varices.  Endoscopy. 1997;  29 235-240
  • 2 Nagamine N, Ueno N, Tomiyama T, et al. A pilot study on modified endoscopic variceal ligation using endoscopic ultrasonography with color Doppler function.  Am J Gastroenterol. 1998;  93 150-155
  • 3 Yamamoto M, Suzuki H. Endoscopic treatment for esophago-gastric varices, current status in Japan.  Hepatogastroenterology. 1997;  44 637-646
  • 4 Hino S, Hayashi T, Kakutani H, et al. Experimental and clinical studies of ICG dye enhanced diode laser photosclerotherapy (in Japanese).  Gastroenterol Endosc. 1998;  40 1657-1665
  • 5 Japanese Research Society for Portal Hypertension . The general rules for recording endoscopic findings on esophageal varices.  Jpn J Surg. 1980;  10 84-87
  • 6 Kiefhaber P, Kiefhaber K, Huber F, et al. Endoscopic neodymium: YAG laser coagulation in gastrointestinal hemorrhage.  Endoscopy. 1986;  18 46-51
  • 7 Fleisher D. Endoscopic Nd:YAG laser therapy for active esophageal variceal bleeding.  Gastrointest Endosc. 1985;  31 4-9
  • 8 Kitano S, Koyanagi N, Iso Y, et al. Prevention of recurrence of esophageal varices after endoscopic injection sclerotherapy with ethanolamine oleate.  Hepatology. 1987;  7 810-815
  • 9 Obara K, Kojima T, Irisawa A, et al. New fibrosing therapy of esophageal varices - laser fibrosing therapy (in Japanese).  Gastroenterol Endosc. 1994;  36 716-721

S. Hino,M.D. 

Digestive Disease Center
Medical University of South Carolina

96 Jonathan Lucas Street #210
Clinical Science Building
Charleston SC 29425, USA


Fax: + 1-843-792-4184

Email: shoryok@attglobal.net

    >